Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Efficacy of esomeprazole in patients with acid-peptic disorders.

Beck J.

Gastroenterol Nurs. 2004 Mar-Apr;27(2):44-9. Review.

PMID:
15082946
2.

Esomeprazole: a review of its use in the management of acid-related disorders in the US.

Scott LJ, Dunn CJ, Mallarkey G, Sharpe M.

Drugs. 2002;62(7):1091-118. Erratum in: Drugs 2002;62(15):2183.

PMID:
11985491
3.

Review of esomeprazole in the treatment of acid disorders.

Johnson DA.

Expert Opin Pharmacother. 2003 Feb;4(2):253-64. Review.

PMID:
12562316
4.

Esomeprazole: a review of its use in the management of acid-related disorders.

Scott LJ, Dunn CJ, Mallarkey G, Sharpe M.

Drugs. 2002;62(10):1503-38. Review.

PMID:
12093317
5.

Esomeprazole.

Spencer CM, Faulds D.

Drugs. 2000 Aug;60(2):321-9; discussion 330-1. Review.

PMID:
10983736
6.

Esomeprazole magnesium (Nexium).

Baker DE.

Rev Gastroenterol Disord. 2001;1(1):32-41. Review.

PMID:
12120118
7.

Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.

Johnson DA, Benjamin SB, Vakil NB, Goldstein JL, Lamet M, Whipple J, Damico D, Hamelin B.

Am J Gastroenterol. 2001 Jan;96(1):27-34. Erratum in: Am J Gastroenterol 2001 Mar;96(3):942.

PMID:
11197282
8.

Esomeprazole: a clinical review.

Johnson TJ, Hedge DD.

Am J Health Syst Pharm. 2002 Jul 15;59(14):1333-9. Review.

PMID:
12132559
9.

A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis.

Raghunath AS, Green JR, Edwards SJ.

Clin Ther. 2003 Jul;25(7):2088-101. Review.

PMID:
12946553
10.

Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.

Castell DO, Kahrilas PJ, Richter JE, Vakil NB, Johnson DA, Zuckerman S, Skammer W, Levine JG.

Am J Gastroenterol. 2002 Mar;97(3):575-83.

PMID:
11922549
11.

Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults.

McKeage K, Blick SK, Croxtall JD, Lyseng-Williamson KA, Keating GM.

Drugs. 2008;68(11):1571-607. Review.

PMID:
18627213
12.

Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators.

Kahrilas PJ, Falk GW, Johnson DA, Schmitt C, Collins DW, Whipple J, D'Amico D, Hamelin B, Joelsson B.

Aliment Pharmacol Ther. 2000 Oct;14(10):1249-58.

13.

Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.

Richter JE, Kahrilas PJ, Johanson J, Maton P, Breiter JR, Hwang C, Marino V, Hamelin B, Levine JG; Esomeprazole Study Investigators..

Am J Gastroenterol. 2001 Mar;96(3):656-65.

PMID:
11280530
14.

Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.

Miner P Jr, Katz PO, Chen Y, Sostek M.

Am J Gastroenterol. 2003 Dec;98(12):2616-20.

PMID:
14687806
15.

Review article: initial therapy of reflux disease with esomeprazole.

Dent J.

Aliment Pharmacol Ther. 2003 Feb;17 Suppl 1:18-20. Review.

16.
17.

Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease.

Lind T, Rydberg L, Kylebäck A, Jonsson A, Andersson T, Hasselgren G, Holmberg J, Röhss K.

Aliment Pharmacol Ther. 2000 Jul;14(7):861-7.

18.

Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis.

Richter JE, Peura D, Benjamin SB, Joelsson B, Whipple J.

Arch Intern Med. 2000 Jun 26;160(12):1810-6.

PMID:
10871975
19.

Esomeprazole for acid peptic disorders.

Kale-Pradhan PB, Landry HK, Sypula WT.

Ann Pharmacother. 2002 Apr;36(4):655-63. Review.

PMID:
11918517
20.

One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease.

Tulassay Z, Kryszewski A, Dite P, Kleczkowski D, Rudzinski J, Bartuzi Z, Hasselgren G, Larkö A, Wrangstadh M.

Eur J Gastroenterol Hepatol. 2001 Dec;13(12):1457-65.

PMID:
11742194
Items per page

Supplemental Content

Support Center